We have previously reported a high detection rate of MYD88 L265P mutations in CSF in primary and secondary CNS lymphoma patients using ddPCR, with a 100% match of the MYD88 L265P mutation status between tumor and CSF in 21 cases with available tumor samples [8]. Here, MYD88 is linked to neoplasm.